FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Summary of Fair Value Hierarchy of Financial Assets Measured at Fair Value

The following tables summarize the fair value hierarchy of the Company's financial assets and liabilities measured at fair value as of December 31, 2019:

	As of December 31, 2019
	Level I		Level II		Level III		Total
Assets	(in thousands)
Investments of consolidated fund	$	110	$	—	$	1,331	$	1,441
Total Assets	$	110	$	—	$	1,331	$	1,441
Liabilities
Due to DB Med Investors (Note 11)	$	—	$	—	$	1,750	$	1,750
Total Liabilities	$	—	$	—	$	1,750	$	1,750

Summary of Changes in Fair Value of Financial Assets Categorized within Level 3

The following is a summary of changes in fair value of the Company's financial assets that have been categorized within Level III of the fair value hierarchy:

	Level III Financial Assets as of September 30, 2020
	Balance at December 31, 2019		Deconsolidation of STRF		Transfers In or (Out) of Level III	Realized and Unrealized Depreciation		Sale of Level III Assets		Balance at September 30, 2020
	(in thousands)
Investments of consolidated fund	$	1,331	(940	)	—	(295	)	(96	)	$	—

Summary of Changes in Fair Value of Financial Liabilities Categorized within Level 3

The following is a summary of changes in fair value of the Company's financial liabilities that have been categorized within Level III of the fair value hierarchy:

	Level III Financial Liabilities as of September 30, 2020
	Balance at December 31, 2019		Settlement of liability to DB Med Investors, at fair value		Payments	Realized and Unrealized Depreciation		Balance at September 30, 2020
	(in thousands)
Due to DB Med Investors (Note 11)	$	1,750	(1,541	)	—	(209	)	$	—